Find the content you are looking for on Diabetech by searching the desired device, company, or topic.
Feb 18, 2026
•
2 min read
We go beyond our Youtube review and cover insurance hurdles, algorithm performance, infusion set challenges, funny stories, and answer follower questions.
4 min read
The device has a customizable 7-inch display designed to display up to six CGM readings at one time making it great for people with diabetes.
Medtronic advances its next-gen tubed pump toward FDA clearance while testing begins on an enhanced algorithm called Vivera.
Feb 17, 2026
The first patients have received its investigational Portal Insulin as development moves toward larger trials in 2027.
We spoke with an FDA-insider about how the organization regulates diabetes tech and how recent political events have shaken up the agency.
Feb 12, 2026
MannKind’s INHALE‐1ST trial is testing an inhaled insulin, as a needle‐free option for children with type 1 diabetes with an expected FDA decision by May 29, 2026.
